20
Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DILTIAZEM HYDROCHLORIDE USP, with a corresponding US DMF Number 15267.
Remarkably, this DMF maintains an Active status since its submission on January 26, 2001, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 15, 2013, and payment made on February 27, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II